Pegylated interferon alfa-2a (40KD) is efficacious and safe in treatment of HBeAg-positive children with chronic hepatitis B: Peg-B-Active study

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共2页
• 作者

  Wirth Stefan; Zhang Hongfei; Hardikar Winita; Schwarz Kathleen B.; Sokal Etienne M.; Yang Weibo; Fan Huimin; Morozov Vyacheslav G.; Mao Qing; Nasmyth-Miller Clare; Huang Yang; Yang Lei; Wat Cynthia;

  展开▼
• 作者单位

  Univ Witten Herdecke Helios Med Ctr Wuppertal Dept Pediat Wuppertal Germany;

  Beijing 302 Hosp Beijing Peoples R China;

  Royal Childrens Hosp Melbourne Vic Australia;

  Johns Hopkins Univ Sch Med Baltimore MD USA;

  Catholic Univ Louvain Clin Univ St Luc Brussels Belgium;

  Kunming Med Coll Affiliated Hosp 1 Kunming Peoples R China;

  8th Peoples Hosp Guangzhou Guangzhou Guangdong Peoples R China;

  MC Hepatolog Samara Russia;

  Third Mil Med Univ Southwest Hosp Chongqing Peoples R China;

  Roche Prod Ltd Welwyn Garden City Herts England;

  Roche China Holding Ltd Shanghai Peoples R China;

  Roche China Holding Ltd Shanghai Peoples R China;

  Roche Prod Ltd Welwyn Garden City Herts England;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词